Home › Companies › CEREVEL THERAPEUTICS HOLDINGS INC. › 2023-2024
Compiled from SEC Form N-PX filings and CEREVEL THERAPEUTICS HOLDINGS INC.’s Form 8-K, filed 2024-02-16 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2023-2024
Explore CEREVEL THERAPEUTICS HOLDINGS INC. in the interactive database Compare manager voting policies
These tallies are CEREVEL THERAPEUTICS HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-02-16 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Proposal 1: Proposal No. 1 - The Merger Proposal : To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of December 6, 2023, by and among AbbVie Inc., a Delaware corporation ("AbbVie"), Symphony H | 168,829,974 | 2,351 | 69,139 | -- | -- | Majority: yes |
| Proposal 2: Proposal No. 2 - The Merger Compensation Proposal : To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Cerevel's named executive officers that is based on or otherwise relates to the Mer | 128,428,961 | 40,275,201 | 197,302 | -- | -- | Majority: yes |
Source: CEREVEL THERAPEUTICS HOLDINGS INC., Form 8-K, filed with the SEC on 2024-02-16 — read the filing on EDGAR.
Each item below shows how the 206 asset managers that disclosed a CEREVEL THERAPEUTICS HOLDINGS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CEREVEL THERAPEUTICS HOLDINGS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
CEREVEL THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Proposal 2: Proposal No. 2 - The Merger Compensation Proposal : To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Cerevel's named executive officers that is ”): 128,428,961 for, 40,275,201 against, per its Form 8-K filed 2024-02-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 200 asset managers below cast 14% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Meeder Advisory Services, Inc. | 0 | 158,000,000 | 0 | 0 | Against |
| Fidelity | 0 | 18,205,594 | 0 | 0 | Against |
| PERCEPTIVE ADVISORS LLC | 9,675,292 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 7,555,555 | 0 | 0 | 0 | For |
| Vanguard | 0 | 7,377,258 | 0 | 0 | Against |
| BlackRock | 17,065 | 5,648,993 | 0 | 0 | Against |
| State Street | 3,070,270 | 23,383 | 0 | 0 | For |
| Rock Springs Capital Management LP | 2,674,245 | 0 | 0 | 0 | For |
| Paradigm Biocapital Advisors LP | 2,214,019 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 1,767,186 | 0 | 0 | Against |
| BAKER BROS. ADVISORS LP | 1,600,000 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 1,319,090 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,298,796 | 0 | 0 | Against |
| AQR | 0 | 1,123,214 | 0 | 0 | Against |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 1,090,317 | 0 | 0 | Against |
| T. Rowe Price | 0 | 1,080,961 | 0 | 0 | Against |
| AllianceBernstein | 0 | 938,577 | 0 | 0 | Against |
| Pentwater Capital Management LP | 0 | 900,937 | 0 | 0 | Against |
| Affinity Asset Advisors, LLC | 750,000 | 0 | 0 | 0 | For |
| Capital Group | 0 | 715,382 | 0 | 0 | Against |
| FARALLON CAPITAL MANAGEMENT LLC | 715,000 | 0 | 0 | 0 | For |
| WATER ISLAND CAPITAL LLC | 611,174 | 0 | 0 | 0 | For |
| American Century | 0 | 598,697 | 0 | 0 | Against |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 553,297 | 13,815 | 0 | 0 | For |
| MERGER FUND | 560,970 | 0 | 0 | 0 | For |
Showing the 25 largest of 200 asset managers. See all 200 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
CEREVEL THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Proposal 1: Proposal No. 1 - The Merger Proposal : To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of December 6, 2023, by and among AbbVie Inc., a Del”): 168,829,974 for, 2,351 against, per its Form 8-K filed 2024-02-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 71 asset managers below cast 100% of the shares they voted on this item FOR (24,414,302 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,167,417 | 0 | 0 | 0 | For |
| Fidelity | 6,735,072 | 0 | 0 | 0 | For |
| BlackRock | 3,207,175 | 0 | 0 | 0 | For |
| State Street | 888,392 | 0 | 0 | 0 | For |
| Charles Schwab | 649,398 | 0 | 0 | 0 | For |
| MERGER FUND | 560,970 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,000 | 0 | 0 | 0 | For |
| AQR | 478,456 | 0 | 0 | 0 | For |
| T. Rowe Price | 439,726 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 426,378 | 0 | 0 | 0 | For |
| Capital Group | 357,691 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 336,770 | 0 | 0 | 0 | For |
| Calamos | 306,460 | 0 | 0 | 0 | For |
| American Century | 296,397 | 0 | 0 | 0 | For |
| Equitable | 185,364 | 0 | 62,560 | 0 | For |
| TIAA | 205,559 | 0 | 0 | 0 | For |
| New York Life | 171,439 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,894 | 0 | 0 | 0 | For |
| Gabelli | 110,000 | 0 | 0 | 0 | For |
| Jackson National | 107,549 | 0 | 0 | 0 | For |
| Brighthouse | 105,246 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 97,489 | 0 | 0 | 0 | For |
| Virtus | 86,313 | 0 | 0 | 0 | For |
| AltShares Trust | 70,409 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 65,023 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.
Combines 2 wordings of this item as funds reported it.
87% fund support · no official result
The 70 asset managers below cast 87% of the shares they voted on this item FOR (21,222,994 for, 3,187,409 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,167,417 | 0 | 0 | 0 | For |
| Fidelity | 5,061,522 | 1,673,550 | 0 | 0 | For |
| BlackRock | 3,207,175 | 0 | 0 | 0 | For |
| State Street | 1,294 | 887,098 | 0 | 0 | Against |
| Charles Schwab | 649,398 | 0 | 0 | 0 | For |
| MERGER FUND | 560,970 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,000 | 0 | 0 | 0 | For |
| AQR | 478,456 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 439,726 | 0 | 0 | Against |
| ARBITRAGE FUNDS | 426,378 | 0 | 0 | 0 | For |
| Capital Group | 357,691 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 336,770 | 0 | 0 | 0 | For |
| Calamos | 306,460 | 0 | 0 | 0 | For |
| American Century | 296,397 | 0 | 0 | 0 | For |
| Equitable | 185,364 | 0 | 62,560 | 0 | For |
| TIAA | 205,559 | 0 | 0 | 0 | For |
| New York Life | 171,439 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,894 | 0 | 0 | 0 | For |
| Gabelli | 110,000 | 0 | 0 | 0 | For |
| Jackson National | 107,549 | 0 | 0 | 0 | For |
| Brighthouse | 23,397 | 77,954 | 3,895 | 0 | Against |
| ALPS ETF Trust | 97,489 | 0 | 0 | 0 | For |
| Virtus | 86,313 | 0 | 0 | 0 | For |
| AltShares Trust | 70,409 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 65,023 | 0 | 0 | 0 | For |
Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.
0% fund support · no official result
The 3 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 624,424 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 619,108 | 0 | 0 | Against |
| JPMorgan | 0 | 4,651 | 0 | 0 | Against |
| Desjardins Global Asset Management Inc. | 0 | 665 | 0 | 0 | Against |
Ranked by the number of CEREVEL THERAPEUTICS HOLDINGS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Meeder Advisory Services, Inc. | 158,000,000 |
| 2 | Fidelity | 18,205,594 |
| 3 | PERCEPTIVE ADVISORS LLC | 9,675,292 |
| 4 | Avoro Capital Advisors LLC | 7,555,555 |
| 5 | Vanguard | 7,377,258 |
| 6 | BlackRock | 5,666,058 |
| 7 | State Street | 3,093,653 |
| 8 | Rock Springs Capital Management LP | 2,674,245 |
| 9 | Paradigm Biocapital Advisors LP | 2,214,019 |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1,767,186 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to CEREVEL THERAPEUTICS HOLDINGS INC. for the 2023-2024 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At CEREVEL THERAPEUTICS HOLDINGS INC.'s shareholder meeting held 2024-02-16, in the 2023-2024 proxy season, 206 asset managers reported how they voted in their SEC Form N-PX filings, covering 814 separate fund positions. Their filings are grouped here into 4 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or… — FOR was 76% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CEREVEL THERAPEUTICS HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-02-16.
CEREVEL THERAPEUTICS HOLDINGS INC. proxy season coverage: 2023-2024 (this page).